Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMO | O15229 | 17/20 | 0.72 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.54 |
| ▸ | AURKA | O14965 | 1/20 | 0.53 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.53 |
| ▸ | PRKACA | P17612 | 1/20 | 0.53 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27864225 | 0.96 | KMO (0.73) | KMOHIF1A | |
| SCHEMBL3183738 | 0.85 | MAPK8 (0.55) | KMOHIF1AAURKAHSP90AA1PRKACA | |
| SCHEMBL27986399 | 0.85 | KMO (0.58) | KMOHIF1AAURKAHSP90AA1PRKACA | |
| SCHEMBL31301438 | 0.84 | KMO (1.00) | KMO | |
| SCHEMBL31301427 | 0.84 | KMO (0.71) | KMO | |
| SCHEMBL28048743 | 0.84 | KMO (0.71) | KMO | |
| SCHEMBL3646330 | 0.83 | KMO (0.64) | KMO | |
| SCHEMBL1669165 | 0.81 | KDM4E (0.57) | KMOHIF1AHSP90AA1 | |
| SCHEMBL30037083 | 0.81 | KDM4E (0.57) | KMOHIF1AHSP90AA1 | |
| SCHEMBL30489168 | 0.81 | MEN1 (0.69) | KMOHIF1AAURKAHSP90AA1PRKACA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5112523-A | High clearing point for liquid crystal displays | CHISSO CORPORATION (JP) | 1992-05-12 | — | — | US | claimed |
| US-4874546-A | LIQUID CRYSTALS | CHISSO CORPORATION (JP) | 1989-10-17 | — | — | US | claimed |
| EP-3810596-B1 | QUINOLINE DERIVATIVES USEFUL AS TYROSINE KINASE INHIBITORS | RIGEL PHARMACEUTICALS INC (US) | 2022-11-30 | — | — | EP | disclosed |
| US-11390589-B2 | Herbicidally active substituted phenylpyrimidines | BAYER AKTIENGESELLSCHAFT (DE) | 2022-07-19 | — | — | US | disclosed |
| WO-2022137033-A1 | ORGANIC METAL COMPLEX, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC EQUIPMENT, AND ILLUMINATION APPARATUS | 株式会社半導体エネルギー研究所 | 2022-06-30 | — | — | WO | disclosed |
| WO-2022137023-A1 | LIGHT EMISSION DEVICE, LIGHT EMISSION APPARATUS, ELECTRONIC EQUIPMENT, AND ILLUMINATION DEVICE | 株式会社半導体エネルギー研究所 | 2022-06-30 | — | — | WO | disclosed |
| WO-2022130107-A1 | LIGHT EMITTING DEVICE, LIGHT EMITTING APPARATUS, ELECTRONIC DEVICE AND LIGHTING DEVICE | 株式会社半導体エネルギー研究所 | 2022-06-23 | — | — | WO | disclosed |
| WO-2022090863-A1 | ORGANIC COMPOUND, CARRIER TRANSPORT MATERIAL, HOST MATERIAL, LIGHT EMITTING DEVICE, LIGHT EMITTING APPARATUS, ELECTRONIC EQUIPMENT, AND LIGHTING APPARATUS | 株式会社半導体エネルギー研究所 | 2022-05-05 | — | — | WO | disclosed |
| WO-2022074499-A1 | LIGHT-EMITTING APPARATUS, ELECTRONIC EQUIPMENT, AND ILLUMINATION APPARATUS | 株式会社半導体エネルギー研究所 | 2022-04-14 | — | — | WO | disclosed |
| WO-2022053905-A1 | ORGANIC METAL COMPLEX, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC EQUIPMENT, AND LIGHTING DEVICE | 株式会社半導体エネルギー研究所 | 2022-03-17 | — | — | WO | disclosed |
| WO-2022023864-A1 | LIGHT EMITTING DEVICE, LIGHT EMITTING APPARATUS, LIGHT EMITTING MODULE, ELECTRONIC DEVICE AND LIGHTING DEVICE | 株式会社半導体エネルギー研究所 | 2022-02-03 | — | — | WO | disclosed |
| EP-2334643-A1 | PHENETHYLAMIDE DERIVATIVES AND THEIR HETEROCYCLIC ANALOGUES | Actelion Pharmaceuticals Ltd. (CH) | 2011-06-22 | — | — | EP | disclosed |
| WO-2010044054-A1 | PHENETHYLAMIDE DERIVATIVES AND THEIR HETEROCYCLIC ANALOGUES | ACTELION PHARMACEUTICALS LTD (CH) | 2010-04-22 | — | — | WO | disclosed |
| US-7485647-B2 | 2-aminoquinoline derivatives | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2009-02-03 | — | — | US | disclosed |
| US-20060287340-A1 | 2-Aminoquinoline derivatives | MSD K.K. (JP) | 2006-12-21 | — | — | US | disclosed |
| EP-1630162-A1 | 2-AMINOQUINOLINE DERIVATIVE | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2006-03-01 | — | — | EP | disclosed |
| US-5112523-A | High clearing point for liquid crystal displays | CHISSO CORPORATION (JP) | 1992-05-12 | — | — | US | disclosed |
| US-5112523-A | High clearing point for liquid crystal displays | CHISSO CORPORATION (JP) | 1992-05-12 | — | — | US | disclosed |
| US-4874546-A | LIQUID CRYSTALS | CHISSO CORPORATION (JP) | 1989-10-17 | — | — | US | disclosed |
| US-4874546-A | LIQUID CRYSTALS | CHISSO CORPORATION (JP) | 1989-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060287340-A1 | 2-Aminoquinoline derivatives | MCHR2, MC2R, MCHR1 | KMO 285/4885HIF1A 1014/4885AURKA 2395/4885 |
| US-11390589-B2 | Herbicidally active substituted phenylpyrimidines | DDT, DPYD, GSTP1 | KMO 1563/4885HIF1A 2571/4885AURKA 3058/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.